Biotech

News

Sangamo sheds staff once again in another retreat

Sangamo Therapeutics has announced another wave of job losses and a plan to license out two lead clinical programmes as it tries to reinvent itself as a neurology-focused

News

Aiolos $245m Series A heads latest crop of biotech rounds

Biotech investment may be somewhat in the doldrums at the moment, but the sector continues to see a steady stream of deals – particularly in the venture capital category –

News

OrbiMed raises $4.3bn for latest biotech funds

International healthcare investment group OrbiMed has raised around $4.3 billion in committed financing for distribution across three new private funds that will be used t

Sales & Marketing

Focussing on finding value in health sciences marketing

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert K

Sales & Marketing

Scientists in the C-suite: Attracting investors takes more t...

In the ever-evolving landscape of the biotechnology sector, the ability to attract investors effectively stands as the decisive factor that separates the success of your pioneering research

News

Agomab raises $100m for Crohn’s drug, and other financings

Agomab Therapeutics has closed a $100 million third-round financing, heading a list of recent funding rounds that also features AstronauTx, MinervaX, Precede Bio and Limma

Sangamo sheds staff once again in another retreat

Aiolos $245m Series A heads latest crop of biotech rounds

OrbiMed raises $4.3bn for latest biotech funds

Focussing on finding value in health sciences marketing

Scientists in the C-suite: Attracting investors takes more t...

Agomab raises $100m for Crohn’s drug, and other financings

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Biotech

Editor's Picks